Literature DB >> 9229194

Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient.

F Capstick1, B A Brooks, C M Burns, R R Zilkens, K S Steinbeck, D K Yue.   

Abstract

Conventional treatment of obese noninsulin dependent diabetes mellitus (NIDDM) patients is often unsatisfactory. In this study the efficacy of Modifast, a commercial very low calorie diet (VLCD), was evaluated in a population of obese poorly controlled NIDDM patients. The mechanisms of action of VLCD in these patients were also studied by comparing: (i) Plasma insulin and glucose profiles after a VLCD and an isocaloric mixed meal and (ii) plasma amino acid levels, both at baseline and after four weeks of VLCD treatment. A total of 14 obese NIDDM patients (M/F 7/7. median body mass index (BMI) 38.7 kg-2, interquartile range (IQ) 34.7-46.5 kg-2, waist circumference 116 cm, IQ 106-139 cm, insulin treated 7/14) with poor diabetic control (HbA1c 8.6%, IQ 7.8-10%) were studied. Patients were given a VLCD (425 kcal/day) for 12 weeks. At baseline, VLCD and isocaloric meal tests were performed on consecutive mornings. Fasting plasma amino acid levels were also determined at baseline and after 4 weeks of VLCD treatment. Weight, waist circumference, HbA1c, blood pressure, fasting plasma insulin, total cholesterol and triglyceride levels all fell significantly following VLCD treatment. Insulin therapy was able to be ceased in the seven insulin treated patients. Oral hypoglycaemic agent dosage fell from a median of eight (IQ 6-12) to two (IQ 0-8) tablets per day (P = 0.03) in patients initially on this form of therapy. Insulin secretion was higher after VLCD than isocaloric meal (P = 0.04). Fasting plasma alanine level fell from 512.0 (IQ 412.0-563.0) to 374.0 (IQ 342-472.0) mumol/l (P = 0.04) following VLCD treatment. In conclusion, the short term use of a VLCD is very effective in rapidly improving glycaemic control and promoting substantial weight loss in obese NIDDM patients. Moreover, a VLCD diet increases insulin secretion and reduces substrate for gluconeogenesis. Thus, VLCD treatment may improve glycaemic control by factors more than caloric restriction alone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9229194     DOI: 10.1016/s0168-8227(97)00038-7

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  12 in total

1.  Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Authors:  M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-05-20       Impact factor: 4.256

2.  The ketogenic diet corrects metabolic hypogonadism and preserves pancreatic ß-cell function in overweight/obese men: a single-arm uncontrolled study.

Authors:  Sandro La Vignera; Rossella Cannarella; Fabio Galvano; Agata Grillo; Antonio Aversa; Laura Cimino; Cristina M Magagnini; Laura M Mongioì; Rosita A Condorelli; Aldo E Calogero
Journal:  Endocrine       Date:  2020-10-15       Impact factor: 3.633

3.  Evidence of a metabolic memory to early-life dietary restriction in male C57BL/6 mice.

Authors:  Colin Selman; Sarah Hempenstall
Journal:  Longev Healthspan       Date:  2012-09-03

4.  Intermittent energy restriction in type 2 diabetes: A short discussion of medication management.

Authors:  Sharayah Carter; Peter M Clifton; Jennifer B Keogh
Journal:  World J Diabetes       Date:  2016-12-15

5.  Immediate and long-term effects of a very-low-calorie diet on diabetes remission and glycemic control in obese Thai patients with type 2 diabetes mellitus.

Authors:  Mongkontida Umphonsathien; Pornsawan Prutanopajai; Juntagan Aiam-O-Ran; Titiprang Thararoop; Apaporn Karin; Chanida Kanjanapha; Wiroj Jiamjarasrangsi; Weerapan Khovidhunkit
Journal:  Food Sci Nutr       Date:  2019-02-11       Impact factor: 2.863

Review 6.  Adjuvant Therapies in Diabetic Retinopathy as an Early Approach to Delay Its Progression: The Importance of Oxidative Stress and Inflammation.

Authors:  Ricardo Raúl Robles-Rivera; José Alberto Castellanos-González; Cecilia Olvera-Montaño; Raúl Alonso Flores-Martin; Ana Karen López-Contreras; Diana Esperanza Arevalo-Simental; Ernesto Germán Cardona-Muñoz; Luis Miguel Roman-Pintos; Adolfo Daniel Rodríguez-Carrizalez
Journal:  Oxid Med Cell Longev       Date:  2020-03-11       Impact factor: 6.543

7.  The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial.

Authors:  Kirsten A C Berk; Hanneke Buijks; Behiye Ozcan; Adriaan Van't Spijker; Jan J V Busschbach; Eric J G Sijbrands
Journal:  BMC Public Health       Date:  2012-11-23       Impact factor: 3.295

Review 8.  Dietary advice for treatment of type 2 diabetes mellitus in adults.

Authors:  L Nield; H J Moore; L Hooper; J K Cruickshank; A Vyas; V Whittaker; C D Summerbell
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

9.  The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review.

Authors:  Catherine Rolland; Alexandra Mavroeidi; Kelly L Johnston; John Broom
Journal:  Diabetes Metab Syndr Obes       Date:  2013-10-11       Impact factor: 3.168

10.  Clinical efficacy of a medically supervised outpatient high-protein, low-calorie diet program is equivalent in prediabetic, diabetic and normoglycemic obese patients.

Authors:  Z Li; C-H Tseng; Q Li; M L Deng; M Wang; D Heber
Journal:  Nutr Diabetes       Date:  2014-02-10       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.